META Pharmaceuticals Inc.
META Pharmaceuticals develops small molecule therapeutics for autoimmune diseases. Their platform focuses on novel drug targets to create treatments that modulate immune responses and reduce inflammation.
- Biotechnology
Updated 18 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- META Pharmaceuticals develops small molecule therapeutics for autoimmune diseases. Their platform focuses on novel drug targets to create treatments that modulate immune responses and reduce inflammation.